RE: Half-year report30 Dec 2022 11:07
Reading between the lines....
"The Company also announced the filing of a new patent application in June 2022 relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans. This followed the completion of a successful human study, the results of which strongly support the use of Fruitflow for modulating gut microbiota to confer a number of health benefits, to include a reduction in TMAO (trimethylamine-n-oxide)."
### we are going after a slice of the Statins pie because it's market over 5 x that of aspirin - yer just need to increase the daily FF dosage.###
"It is intended that the Company will pay DSM for this inventory over the course of a three month sale back period, commencing on 1 January 2023, with payments due equally (amounting to one third of DSM's 31 December 2022 inventory) on 31 January 2023, 28 February 2023 and 31 March 2023. "
#### we expect to shift a million euros worth of stock over three months. Over a year current sales are around 4 million euros. At this stage we won't tell yer our profit margin, but it's gonna be better than DSMs cos we ain't a big corporation (that seems to have lost its way if its share price is anything to go by). Stuart put a spreadsheet together for us that showed we could make more money if we went it alone. But we have good friends at DSM and we ain't got the cash to pay for the Prof's latest wheeze on statins so we're going keep working with them 'cos we like collaborations and it gives Niamh something new to do.###
"The Company's supply and distribution agreement for Fruitflow with By-Health, which was announced in November 2021, will take full effect from 1 January 2023. By-Health will file its regulatory submission to the SAMR for Fruitflow at the appropriate time, seeking to obtain a new permitted health function claim for foods such as Fruitflow that can demonstrate an anti-platelet effect. If By-Health is successful in obtaining a new permitted health function claim, it is currently expected that this would result in some significant orders for Fruitflow, potentially at a multiple of current total sales values."
###we dunno what's going on in China, but Felix still says it's all going fine. We also don't know what is going on with Nitrates either but the Prof has updated his wiki page so he must be expecting more views which could be linked to a launch of a new product that we won't keep a secret.###
aimho
Happy New Year !!
W$
We
The Company expects that the new gut microbiome patent application, and the other significant changes announced in June 2022 to the sales and supply chain structure for Fruitflow, will have a strongly beneficial effect on the current and future commercial prospects for Fruitflow and the business worldwide.
Sign In
Follow the stocks
